01GSK plc will report Q3 2026 earnings on October 28, 2026 after market close with analysts expecting $1.40 EPS and $11.8B revenue.
02The stock trades at $50.94 with a $99.4B market capitalization as of the article date.
03GSK has beaten earnings estimates in the last three quarters, with Q2 reporting $1.35 actual EPS versus $1.27 estimate.
04Revenue growth, margin trends, and forward guidance are expected to be more important than headline EPS in determining stock direction.
Earnings Results
GSK plc (NYSE:GSK) is scheduled to report its Q3 earnings results on October 28, 2026 after market close.
Analysts expect the Healthcare company to report earnings per share of $1.40, above the $0.00 reported in the same quarter last year. Revenue is expected to come in at $11.8B, up from a year ago.
Company Overview
The stock currently trades at $50.94 with a market capitalization of $99.4B.
Ahead of GSK plc's earnings report, investors are watching several key metrics beyond the headline EPS number. Revenue growth, margin trends, and forward guidance will likely carry more weight than a single quarter's earnings figure in determining the stock's direction after the report.
Earnings reports are most useful when viewed as part of a trend rather than in isolation. Investors tracking GSK plc should compare this quarter's results against both year-over-year figures and sequential performance to identify whether the business is accelerating, stabilizing, or decelerating. The earnings calendar on Smart Investors Daily tracks upcoming report dates across all publicly traded companies.